We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+15.2%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$2.07B
AUM Growth
+$251M
Cap. Flow
-$68.7M
Cap. Flow %
-3.32%
Top 10 Hldgs %
44.01%
Holding
2,647
New
722
Increased
455
Reduced
467
Closed
877

Sector Composition

Rank Sector Weight
1 Technology 6.57%
2 Consumer Discretionary 4.71%
3 Industrials 3.64%
4 Healthcare 3.58%
5 Communication Services 3.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DM
1676
CALL
DELISTED
Desktop Metal, Inc.
DM
$2K ﹤0.01%
+20
New +$2.16K
SUM
1677
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$2K ﹤0.01%
+102
New +$1.63K
BCOV
1678
DELISTED
Brightcove, Inc.
BCOV
$2K ﹤0.01%
221
-2,133
-91% -$21.3K
VGR
1679
DELISTED
Vector Group Ltd.
VGR
$2K ﹤0.01%
282
-141
-33% -$961
EIGR
1680
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$2K ﹤0.01%
+10
New +$3.11K
MARK
1681
CALL
DELISTED
Remark Holdings, Inc.
MARK
$2K ﹤0.01%
160
-100
-38% -$1.39K
SDC
1682
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$2K ﹤0.01%
200
-500
-71% -$4.59K
IDEX
1683
CALL
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$2K ﹤0.01%
14
-69
-83% -$11K
TA
1684
DELISTED
TravelCenters of America LLC
TA
$2K ﹤0.01%
+100
New +$1.72K
JNCE
1685
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$2K ﹤0.01%
+200
New +$1.24K
AMPE
1686
CALL
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$2K ﹤0.01%
7
USAK
1687
DELISTED
USA Truck Inc
USAK
$2K ﹤0.01%
+200
New +$2.04K
ENDP
1688
CALL
DELISTED
Endo International plc
ENDP
$2K ﹤0.01%
+700
New +$2.25K
PAE
1689
DELISTED
PAE Incorporated Class A Common Stock
PAE
$2K ﹤0.01%
+200
New +$1.78K
CVA
1690
DELISTED
Covanta Holding Corporation
CVA
$2K ﹤0.01%
+200
New +$1.83K
PRCP
1691
CALL
DELISTED
Perceptron Inc
PRCP
$2K ﹤0.01%
+300
New +$1.3K
AKCA
1692
CALL
DELISTED
Akcea Therapeutics Inc
AKCA
$2K ﹤0.01%
+100
New +$1.42K
MNK
1693
CALL
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$2K ﹤0.01%
+2,000
New +$3.54K
TEUM
1694
CALL
DELISTED
Pareteum Corporation
TEUM
$2K ﹤0.01%
3,000
+200
+7% +$134
TACO
1695
DELISTED
Del Taco Restaurants, Inc. Common Stock
TACO
$2K ﹤0.01%
+200
New +$1.55K
ACI icon
1696
Albertsons Companies
ACI
$6.02B
$1K ﹤0.01%
+100
New +$1.46K
AEG icon
1697
CALL
Aegon
AEG
$13.9B
$1K ﹤0.01%
+434
New +$1.15K
AGEN
1698
CALL
Agenus
AGEN
$315M
$1K ﹤0.01%
15
AOSL icon
1699
Alpha and Omega Semiconductor
AOSL
$916M
$1K ﹤0.01%
+100
New +$1.21K
AOUT icon
1700
American Outdoor Brands
AOUT
$161M
$1K ﹤0.01%
+50
New +$728

Similar funds

Prelude Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, Prelude Capital Management held 2,647 positions worth $2.07B, up 14% from $1.82B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Prelude Capital Management withdrew a net $68.7M in Q3 2020, closing 877 positions and reducing 467 holdings. Its most notable exit was Invesco QQQ Trust, an estimated $9.18M position sold in full.

By sector, the portfolio is most concentrated in Technology at 6.6% of assets, down from 7% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Prelude Capital Management opened a new position in Equitrans Midstream Corporation Common Stock worth $14.9M.

  • Prelude Capital Management's largest Q3 2020 buy was Equitrans Midstream Corporation Common Stock: 1,760,179 shares worth $14.9M.
  • Prelude Capital Management added most to Alibaba in Q3 2020, an estimated $12.1M increase.
  • Prelude Capital Management's biggest Q3 2020 reduction was Broadcom, cutting an estimated $5.72M.
  • Prelude Capital Management fully exited Invesco QQQ Trust in Q3 2020, selling an estimated $9.18M.
  • Prelude Capital Management's ten largest holdings make up 44% of its $2.07B portfolio in Q3 2020.
  • Prelude Capital Management opened 722 new positions and closed 877 in Q3 2020.
  • Prelude Capital Management's portfolio value rose 14% quarter-over-quarter to $2.07B.

Based on Prelude Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.